Experiment 520926
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | FORASTIERE,AA:. (1994). PACLITAXEL (TAXOL) FOR THE TREATMENT OF HEAD AND NECK CANCER.. 21(5) |
| Amount utilized | |
| Compound isolated | |
| Disease | REVIEW OF A PHASE II STUDIES OF CMPD IN TREATING RECURRENT HEAD AND NECK CANCER. COMPLETE AND PARTIAL RESPONSES SEEN IN 40% AFTER 24 HOUR DOSING WITH G-CSF IN EASTERN COOPERATIVE ONCOLOGY GROUP STUDY. NEUTROPENIA, PERIPHERAL SENSORY NEURO- PATHY AND MYALGIAS/ARTHRALGIAS SEEN AS SIDE-EFFECTS. EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER AND OHIO STATE UNIV STUDIES IN PROGRESS. |
| Dose amount | 250.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |